System Transmission

Top Signal

100#1 JOB

Activity

2191Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

MYGN

$4.66-3.92%

Myriad Genetics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

15Overripe

Live Analysis Active

Company Mission

Myriad Genetics creates genetic tests that look at your DNA to check for cancer risks and help doctors choose the right treatments. Doctors order these tests for patients who might have inherited cancer risks or need personalized treatment plans. The company makes money by selling these genetic tests to healthcare providers and patients, with insurance companies often paying for them.

MYG

Industry Context

Myriad Genetics operates in the healthcare diagnostics industry, specifically genetic testing. This sector is growing as personalized medicine advances, but faces challenges with insurance coverage and regulatory changes that affect how tests are paid for.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

56Matrix

Market Momentum

41.1— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-3.92%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MYGN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:02 PM UTC

As-of 03-15-2026 13:46 UTC

Develops genetic tests that predict cancer risks and makes money by selling these tests to doctors and hospitals.

Price is compressing on the weekly chart near recent lows, suggesting potential volatility expansion soon as the range tightens showing showing.

Healthcare sector faces regulatory uncertainty around genetic testing reimbursement, which could impact companies like Myriad Genetics.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...